(XNCR) Xencor - Performance -62.9% in 12m
Compare XNCR with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-78.70%
#104 in Group
Rel. Strength
10.09%
#7154 in Universe
Total Return 12m
-62.85%
#116 in Group
Total Return 5y
-72.78%
#70 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -48.26%
(?) Percentile in Group
12m Total Return: XNCR (-62.9%) vs XBI (-12.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: XNCR vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for XNCR
Total Return (including Dividends) | XNCR | XBI | S&P 500 |
---|---|---|---|
1 Month | 14.60% | 11.81% | 13.81% |
3 Months | -47.77% | -13.61% | -6.30% |
12 Months | -62.85% | -12.29% | 10.65% |
5 Years | -72.78% | -24.89% | 107.77% |
Trend Score (consistency of price movement) | XNCR | XBI | S&P 500 |
1 Month | 26.0% | 72.9% | 83% |
3 Months | -87.6% | -83% | -75.3% |
12 Months | -48.5% | -51.6% | 50.1% |
5 Years | -87.3% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #62 | 2.50% | 0.69% |
3 Month | #162 | -39.5% | -44.3% |
12 Month | #117 | -57.6% | -66.4% |
5 Years | #73 | -63.8% | -86.9% |
FAQs
Does XNCR Xencor outperforms the market?
No,
over the last 12 months XNCR made -62.85%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months XNCR made -47.77%, while XBI made -13.61%.
Over the last 3 months XNCR made -47.77%, while XBI made -13.61%.
Performance Comparison XNCR vs Indeces and Sectors
XNCR vs. Indices XNCR is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -20.2% | 0.79% | -57.9% | -73.5% |
US NASDAQ 100 | QQQ | -20.4% | -2.76% | -58.1% | -74.5% |
US Dow Jones Industrial 30 | DIA | -20.7% | 4.61% | -57.6% | -70.6% |
German DAX 40 | DAX | -20.2% | -0.36% | -84.1% | -88.6% |
Shanghai Shenzhen CSI 300 | CSI 300 | -22.4% | 2.77% | -58.6% | -70.2% |
Hongkong Hang Seng | HSI | -23.4% | -5.33% | -66.2% | -76.5% |
India NIFTY 50 | INDA | -15.3% | 9.76% | -58.3% | -62.6% |
Brasil Bovespa | EWZ | -21.3% | -2.64% | -66.6% | -54.5% |
XNCR vs. Sectors XNCR is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -20.9% | 1.19% | -64.9% | -84.4% |
Consumer Discretionary | XLY | -20.6% | 0.37% | -56.9% | -77.1% |
Consumer Staples | XLP | -19.4% | 8.01% | -64.8% | -72.0% |
Energy | XLE | -20.1% | 7.84% | -51.3% | -53.4% |
Financial | XLF | -21.3% | 1.08% | -65.0% | -85.3% |
Health Care | XLV | -17.2% | 13.7% | -52.9% | -58.8% |
Industrial | XLI | -21.9% | -2.22% | -59.3% | -73.8% |
Materials | XLB | -20.0% | 1.04% | -53.0% | -57.6% |
Real Estate | XLRE | -18.9% | 3.06% | -58.6% | -78.3% |
Technology | XLK | -21.3% | -6.62% | -55.0% | -70.0% |
Utilities | XLU | -20.3% | 5.01% | -65.5% | -80.3% |
Aerospace & Defense | XAR | -22.2% | -6.56% | -69.4% | -90.2% |
Biotech | XBI | -13.7% | 2.79% | -37.7% | -50.6% |
Homebuilder | XHB | -20.7% | 3.12% | -44.7% | -55.3% |
Retail | XRT | -22.1% | -0.05% | -53.6% | -61.4% |